Risdiplam | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Risdiplam
Health Canada Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Risdiplam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 5 USDMF, 1 NDC API, 5 Listed Suppliers, $ API Reference Price

8 API Suppliers
5 USDMF
1 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

67 Drugs in Development

67 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 2 FDA Orange Book, 1 Canada, 20 Australia, 1 South Africa

24 FDF Dossiers
2 FDA Orange Book
1 Canada
20 Australia
1 South Africa

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 90 News #PharmaBuzz

1 Data Compilation #PharmaFlow
90 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Annual Reports

1 US Medicaid Prescriptions
4 Annual Reports

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

13 US Patents, 7 US Exclusivities, 4 Health Canada Patents

13 US Patents
7 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 777,093 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 12863874

02 12948561

03 13002494

04 13116458

filter Product Reset all filters

4 All

01 4RISDIPLAM

filter Dosage Reset all filters

4 All

01 4POWDER FOR SOLUTION

filter Exp Date Reset all filters

4 All

01 12033-02-08

02 12035-05-11

03 12036-11-08

04 12039-10-18

Product Main Page

01

Gowling WLG (Canada) LLP

RISDIPLAM

Boulder Peptide

Not Confirmed

Gowling WLG (Canada) LLP

Country

Boulder Peptide

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-08

Date Granted : 2021-01-12

Brand Name : EVRYSDI

Patent Number : 3002494

Filing Date : 2016-11-08

Strength per Unit : 0.75mg / mL (after reconstitution)

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-11-08

Date Granted : 2021-01-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

RISDIPLAM

Boulder Peptide

Not Confirmed

Gowling WLG (Canada) LLP

Country

Boulder Peptide

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-08

Date Granted : 2021-02-16

Brand Name : EVRYSDI

Patent Number : 2863874

Filing Date : 2013-02-08

Strength per Unit : 0.75mg / mL (after reconstitution)

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-02-08

Date Granted : 2021-02-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

RISDIPLAM

Boulder Peptide

Not Confirmed

Gowling WLG (Canada) LLP

Country

Boulder Peptide

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-11

Date Granted : 2019-10-22

Brand Name : EVRYSDI

Patent Number : 2948561

Filing Date : 2015-05-11

Strength per Unit : 0.75mg / mL (after reconstitution)

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-05-11

Date Granted : 2019-10-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

RISDIPLAM

Boulder Peptide

Not Confirmed

Gowling WLG (Canada) LLP

Country

Boulder Peptide

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-18

Date Granted : 2023-12-12

Brand Name : EVRYSDI

Patent Number : 3116458

Filing Date : 2019-10-18

Strength per Unit : 0.75mg / mL (after reconstitution)

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2039-10-18

Date Granted : 2023-12-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!